Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NR3C1 | hg38_v1_chr5_-_143404536_143404667 | -0.32 | 7.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_22895368 Show fit | 11.41 |
ENST00000390321.2
|
immunoglobulin lambda constant 1 |
|
chr14_-_105987068 Show fit | 10.76 |
ENST00000390594.3
|
immunoglobulin heavy variable 1-2 |
|
chr22_+_22906342 Show fit | 10.74 |
ENST00000390325.2
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
|
chr22_+_22900976 Show fit | 9.79 |
ENST00000390323.2
|
immunoglobulin lambda constant 2 |
|
chr14_-_105588322 Show fit | 8.83 |
ENST00000497872.4
ENST00000390539.2 |
immunoglobulin heavy constant alpha 2 (A2m marker) |
|
chr2_-_89010515 Show fit | 8.58 |
ENST00000493819.1
|
immunoglobulin kappa variable 1-9 |
|
chr2_-_89040745 Show fit | 7.58 |
ENST00000480492.1
|
immunoglobulin kappa variable 1-12 |
|
chr15_-_21718245 Show fit | 7.23 |
ENST00000630556.1
|
novel gene identicle to IGHV1OR15-1 |
|
chr2_+_89959979 Show fit | 7.14 |
ENST00000453166.2
|
immunoglobulin kappa variable 2D-28 |
|
chr14_-_106235582 Show fit | 6.60 |
ENST00000390607.2
|
immunoglobulin heavy variable 3-21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 231.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 34.9 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 26.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 12.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 10.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.8 | 9.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 9.7 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
2.9 | 8.8 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
0.1 | 8.8 | GO:0006968 | cellular defense response(GO:0006968) |
1.4 | 8.3 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 85.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 71.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 57.6 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 25.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
2.9 | 14.6 | GO:0071750 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
0.1 | 11.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 10.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 9.6 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 7.9 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.2 | 7.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 156.4 | GO:0003823 | antigen binding(GO:0003823) |
1.4 | 101.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 13.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 10.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.1 | 9.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 8.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 8.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 7.8 | GO:0005178 | integrin binding(GO:0005178) |
2.5 | 7.6 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.6 | 7.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 18.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 16.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 10.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 9.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 9.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 7.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 7.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 6.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 5.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 5.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 20.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 15.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 14.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.7 | 10.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 10.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 10.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.3 | 9.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 9.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 7.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.2 | 7.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |